CEDARLANE LABORATORIES USA, INC

Cedarlane Laboratories USA, Inc. specializes in the manufacturing of biological products, with demonstrated expertise in the production of pneumococcus antigens for use in immunological research and vaccine development. The company’s core capabilities center on precision biomanufacturing processes, including antigen purification, characterization, and formulation under controlled laboratory conditions. Their technical proficiency spans microbial culture systems, protein isolation techniques, and quality control protocols compliant with Good Manufacturing Practices (GMP) for biological agents. Cedarlane’s specialization in pneumococcal antigens indicates a focused capability in pathogen-derived immunogens, supporting downstream applications in diagnostics, therapeutics, and preclinical vaccine research. Their ability to deliver consistent, high-purity antigen batches suggests strong process validation and batch-to-batch reproducibility—critical for federal research and public health initiatives. The company has established a direct working relationship with the Department of Health and Human Services, providing specialized biological materials that support infectious disease research and preparedness programs. This engagement reflects a trusted supplier role within HHS-funded initiatives, likely supporting agencies such as NIH, CDC, or BARDA through the provision of critical reagents for immunological studies and vaccine candidate evaluation. Cedarlane’s primary industry focus is in biological product manufacturing (NAICS 325414), a niche sector requiring stringent regulatory alignment and sterile processing environments. The company positions itself as a specialized producer of non-diagnostic biological agents, serving the biodefense, immunology, and pharmaceutical research markets. Their market presence is defined by technical precision rather than broad product portfolios, making them a targeted partner for agencies requiring custom or low-volume antigen supplies. Cedarlane Laboratories USA, Inc. is a small, privately held entity based in Burlington, North Carolina, with no publicly listed government certifications. Its operational footprint is centered in the Southeastern U.S., with a focused presence in the federal life sciences supply chain. The company’s structure and location support agile, mission-critical production for government-funded biomedical programs.